C
Chantal B.E.M. Reusken
Researcher at Erasmus University Rotterdam
Publications - 52
Citations - 13819
Chantal B.E.M. Reusken is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 27 publications receiving 10420 citations. Previous affiliations of Chantal B.E.M. Reusken include Erasmus University Medical Center.
Papers
More filters
Journal ArticleDOI
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors
Maurice Steenhuis,Gerard van Mierlo,Ninotska I. L. Derksen,Pleuni Ooijevaar-de Heer,Simone Kruithof,Floris L. Loeff,Lea C. Berkhout,Federica Linty,Chantal B.E.M. Reusken,Johan Reimerink,Boris M. Hogema,Hans L. Zaaijer,Leo van de Watering,Francis Swaneveld,Marit J. van Gils,Berend Jan Bosch,Marieke van Ham,Anja ten Brinke,Gestur Vidarsson,Ellen van der Schoot,Theo Rispens +20 more
TL;DR: In this paper, the authors measured antibody responses to the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein and the nucleocapsid protein in 844 longitudinal samples from 151 RT-PCR-positive SARS CoV2 convalescent adults during the first 250 days after onset of symptoms.
Posted ContentDOI
SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium
Mart M. Lamers,Anna Z Mykytyn,Tim I Breugem,Nathalie Groen,Kèvin Knoops,Debby Schipper,Romy van Acker,Petra B. van den Doel,Theo M. Bestebroer,Charlotte D. Koopman,Chantal B.E.M. Reusken,Mauro J. Muraro,Corine H. GeurtsvanKessel,Martin E. van Royen,Peter J. Peters,Jingshu Zhang,Bart L. Haagmans +16 more
TL;DR: It is reported that Omicron replicates more rapidly in the airways and has an increased fitness compared to the early 614G variant and Delta, and Mechanistically, it is shown that OMicron does not efficiently use TMPRSS2 for entry or spread through cell-cell fusion.
Journal ArticleDOI
Molecular typing of Coxiella burnetii from animal and environmental matrices during Q fever epidemics in the Netherlands.
Arnout de Bruin,Pleunie T W van Alphen,Rozemarijn Q. J. van der Plaats,Lianne de Heer,Chantal B.E.M. Reusken,Bart J. van Rotterdam,Ingmar Janse +6 more
TL;DR: A multiplex multi-locus variable number of tandem repeats analysis (MLVA) assay was used to investigate the genotypic diversity of C. burnetii in different types of samples that were collected nationwide during the Dutch Q fever outbreaks between 2007 and 2010.
Journal ArticleDOI
Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
Pere Millat-Martinez,Arvind Gharbharan,Andrea Alemany,Casper Rokx,Carlijn C E Jordans,Geert H. Groeneveld,Ellen van der Schoot,Marc Corbacho-Monné,Dan Ouchi,Pierre Malchair,Sebastián Videla,Vanesa García García,Anna Ruiz-Comellas,Joan Ramon Grifols,Julián Jesús Blanco,Ignacio Blanco,Jordi Ara,Bonaventura Clotet,Bàrbara Baro,Andrea B. Troxel,Jaap Jan Zwaginga,Oriol Mitjà,Bart J. A. Rijnders,Corine H. GeurtsvanKessel,G. Papageourgiou,Peter D. Katsikis,Yvonne Müller,Marion Koopmans,Susanne Bogers,Jelle R. Miedema,Henk Russcher,C. R. Scherpenisse,Rene van Engen,Ayten Karisli,Hannelore M Götz,Jelle Struik,Lotte Rokx-Niemantsverdriet,Nan van Geloven,Gert Groeneveld,L. Zwaginga,J. A. Oud,Romy Meier,Erik W. van Zwet,Simon P. Mooijaart,Arjan Albersen,Francis H. Swaneveld,H. Vrielink,L. M. G. van de Watering,Boris M. Hogema,Peter van Wijngaarden,R. W. Van Etten,Adriaan J. van Gammeren,N Maas,B. van Ginneken,Jan G den Hollander,J. Verstijnen,Juliette van den Berg – Rahman,Faiz Karim,Siepke Hiddema,Kim van Elst,Elena M. van Leeuwen-Segarceanu,A. Reitsma,Karin Molenkamp,Robin Soetekouw,Caterina Band,José de Droog,Jolanda Lammers,L Buitenhuis,Douwe F. Postma,D. Koster,Michael Lukens,T.A. Scholtens,Maria A van den Boomgaard,Machiel Vonk,L. M. Kampschreur,Marit G. A. van Vonderen,Loes B Vrolijk,Chantal B.E.M. Reusken,Johan Reimerink,Heli Harvala,Gèlia Costes,Mar Capdevila-Jáuregui,Pamela Torrano-Soler,Alba San José,Zahida Jiménez,Ferran Ramírez-Viaplana,S. Ferrer,M J Morales Gallardo,María Ubals,Camila González-Beiras,Martí Vall-Mayans,Miquel Àngel Rodríguez-Arias,Clara Suñer,Jordi Puig,Aroa Nieto,Iván Galván-Femenía,Xavier Comas-Leon,Quique Bassat,Glòria Bonet Papell,M. Delgado Capel,Beatriz Díez Sánchez,Maria Pons Barber,C. Gonzalez Ruiz,Laura Navarrete Gonzalez,D. González García,Ainhoa Vivero Larraza,Victor Carceles Peiró,Clàudia Roquer López,Magí Ferrer,Carlota Gudiol,A. Otero,José Carlos Ruibal Suárez,Alvaro Zarauza Pellejero,F. Llopis Roca,Orlando Rodriguez Cortez,Pablo Casares Gonzalez,Gemma Arcos Vila,Begoña Flores Aguilera,Graciela Rodríguez-Sevilla,Macarena Dastis Arias,Anna Ramírez-Morros,Judit Roca Font,Katherine M. Carrasco Matos,Glòria Saüch Valmaña,Carla Vidal Obradors,Joana Rodríguez Codina,Rosa Amado Simon,Silvia Tarres García,Margarida Curriu Sabatès,Raquel Nieto Rodríguez,Anna Millan,E. Contreras,Agueda Ancochea,Rosa Linio,Míriam Fornos,Natalia Casamitjana,Eva Alonso,Nuria Martínez,Laura Maglio,Laura Comellas Fernandez,Nadia García,Luis Hernández,Maria Isabel Martínez González,Anna Bravo,Yolanda M. Guerra García,Nuria Prat,J. Verdaguer,Thatiana Vértiz Guidotti,S. Benavent,Andrea Bianco,Ney Nicanor Briones Zambrano,Maria Viozquez Meya,Anna Forcada,Josep Vidal-Alaball,Montserrat Giménez,A.N. Paris,Gema Fernandez Rivas,Cristina Casañ López,Agueda Hernandez,Antoni E. Bordoy,Victoria González Soler,Julià Blanco,Edwars Pradenas,Silvia Marfil,Benjamin Trinité,Francini Piccolo Ferreira,Mireia Jofre Bonet,Jordi Cantoni,Michael Marks +168 more
TL;DR: In this paper , convalescent plasma (CP) treatment in COVID-19 outpatients was evaluated to assess whether CP administered during the first week of symptoms reduced the disease progression or risk of hospitalization.
Posted ContentDOI
Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022
Stijn P. Andeweg,Brechje de Gier,Dirk Eggink,Caroline van den Ende,Noortje M van Maarseveen,Lubna Ali,B. Vlaemynck,Raf Schepers,Susan Hahné,Chantal B.E.M. Reusken,Hester E. de Melker,S. van den Hof,Mirjam J. Knol +12 more
TL;DR: Primary vaccination with current COVID-19 vaccines and pre-Omicron SARS-CoV-2 infections offer low protection against Omicron BA.1 infection, but booster vaccination considerably increases protection, although protection remains lower than against Delta.